Posted On: 05/22/2012 9:47:47 AM
Post# of 99250
| DOWJONES | Genta To Proceed With New Trial Of Tesetaxel As Initial, Single-Agent Chemotherapy For Recurrent Breast Cancer Patients |
Genta To Proceed With New Trial Of Tesetaxel As Initial, Single-Agent
Chemotherapy For Recurrent Breast Cancer Patients
Last Update: 5/22/2012 9:07:16 AM
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
May 22, 2012 09:07 ET (13:07 GMT) 
(0)
(0)
